Hydrogen sulphide in heart and systemic circulation

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 2, 2011, Pages 103-108

  Bucci, Mariarosaria ^a   Cirino, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis; Cardioprotection; cGMP; Hydrogen sulphide; Phosphodiesterase; Vasodilatation

Indexed keywords

CYCLIC GMP; CYSTEINE; HYDROGEN SULFIDE; PHOSPHODIESTERASE; POTASSIUM CHANNEL;

ANGIOGENESIS; ARTICLE; BLOOD PRESSURE; CORPUS CAVERNOSUM; HEART; HEART PROTECTION; MESENTERIC ARTERY; SYSTEMIC CIRCULATION; VASCULAR RESISTANCE;

EID: 79952746151     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811794776204     Document Type: Article

References (61)

1. Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Disc., 2007, 11, 917-935.
2. Wang, R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J., 2002, 16, 1792-1798.
3. Whitfield, N.L.; Kreimier, E.L.; Verdial, F.C.; Skovgaard, N.; Olson, K.R. Reappraisal of H2S/sulphide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signalling. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 294, R1930-R1937.
4. Li, L.; Moore, P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol. Sci., 2008, 29(2), 84-90.
5. Li, L.; Moore, P.K. An overview of the biological significance of endogenous gases: new roles for old molecules. Biochem. Soc. Trans., 2007, 35, 1138-1141.
6. Shibuya, N.; Mikami, Y.; Kimura, Y.; Nagahara, N.; Kimura, H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produce hydrogen sulphide. J. Biochem., 2009, 146, 623-626.
7. Brancaleone, V.; Roviezzo, F.; Vellecco, V.; De Gruttola, L.; Bucci, M.; Cirino, G. Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br. J. Pharmacol., 2008, 155, 673-680.
8. Mok, Y.Y.; Atan, M.S.; Yoke, P.C.; Zhong Jing, W.; Bhatia, M.; Moochhala, S.; Moore, P.K. Role of hydrogen sulphide in haemorragic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br. J. Pharmacol., 2004, 143, 881-889.
9. Hui, Y.; Du, J.; Tang, C.; Bin, G.; Jiang, H. Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J. Infect., 2003, 47, 155-160.
10. Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulphide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun., 1997, 237, 527-531.
11. Cheng, Y.; Ndisang, J.F.; Tang, G.; Cao, K.; Wang, R. Hydrogen sulphide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol., 2004, 287, H2316-H2323.
12. Zhao, W.; Zhang, J.; Lu, Y.; Wang, R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J., 2001, 20, 6008-6016.
13. Zhao, W.; Wang, R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart. Circ. Physiol., 2002, 283, H474-H480.
14. Koenitzer, J.R.; Isbell, T.S.; Patel, H.D.; Benavides, G.A.; Dickinson, D.A.; Patel, R.P.; Darley-Usmar, V.M.; Lancaster, J.R. Jr; Doeller, J.E.; Kraus, D.W. Hydrogen sulphide mediates vasoactivity in a O2-dependent manner. Am. J. Physiol. Heart Circ. Physiol., 2007, 292, H1953-H1960.
15. Ali, M.Y.; Ping, C.Y.; Mok, Y.Y.; Ling, L. Whiteman, M.; Bhatia, M.; Moore, P.K. Regulation of vascular nitric oxide in vitro and in vivo, a new role for endogenous hydrogen sulphide? Br. J. Pharmacol., 2006, 149, 625-634.
16. Elsey, D.J.; Fowkes, R.C.; Baxter, G.F. Regulation of cardiovascular cell function by hydrogen sulphide (H2S). Cell Biochem. Funct., 2010, 28, 95-106.
17. Dombkowski, R.A.; Russel, M.J.; Schulman, A.A.; Doellman, M.M.; Holson, K.R. Vertebrate phylogeny of hydrogen sulphide vasoactivity. Am. J. Physiol., 2005, 288, R243-R252.
18. Tang, G.; Wu, L.; Liang, W.; Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulphide in vascular smooth muscle cells. Mol. Pharmacol., 2005, 68, 1757-1764.
19. Leffler, C.W.; Parfenova, H.; Jaggar, J.H.; Wang, R. Carbon monoxide and hydrogen sulphide: gaseous messengers in cerebrovascular circulation. J. Appl. Physiol., 2006, 100, 1065-1076.
20. Kubo, S.; Kajiwara, M.; Kawabata A. Dual modulation of the tension of isolated gastric artery and gastric mucosa circulation by hydrogen sulphide in rats. Inflammopharmacology, 2007, 15, 288-292.
21. Webb, G.D.; Lim, L.H.; Oh, V.M. Contractile and vasorelaxant effects of hydrogen sulphide and its biosynthesis in the human internal mammary artery. JPET, 2008, 324, 876-882.
22. Zhao, W.; Zhang, J.; Lu, Y.; Wang, R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J., 2001, 20, 6008-6016.
23. Yang, G.; Wu, L.; Jiang, B.; Yang, W.; Qi, J.; Cao, K.; Meng, Q.; Mustafa, A.; Mu, W.; Zhang, S.; Snyder, S.; Wang, R. H2S ha a physiologic vasorelaxant:hypertension in mice with deletion of cystationine-gamma-lyase. Science, 2008, 322, 587-590.
24. Bucci, M.; Papapetropoulos, A.; Vellecco, V.; Zhou, Z.; Pyriochou, A.; Rosussos, C.; Roviezzo, F.; Brancaleone, V.; Cirino, G. Hydrogen Sulphide is an endogenous inhibitor of phosphodiesterase activity. ATVB, 2010, 30(10), 1998-2004.
25. Bender, A.; Beavo, J. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev., 2006, 58, 433-520.
26. Laggner, H.; Hermann, M.; Esterbauer, H.; Muellner, M.K.; Exner, M.; Gmeiner, B.M.; Kapiotis, S. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J. Hypertens., 2007, 25(10), 2100-2104.
27. Mustafa, A.; Gadalla, M.; Sen, N.; Kim, S.; Mu, W.; Gazi, S.; Barrow, R.; Yang, G.; Wang, R.; Snyder, S. H2S signals through protein S-sulphydration. Sci. Signal., 2009, 2, ra72.
28. Alioua, A.; Tanaka, Y.; Wallner, M.; Hofmann, F.; Ruth, P.; Meera, P.; Toro, L. The large conductance, voltage dependent, and calcium-sensitive K+ channel, Hslo is a target of cGMP-dependent protein kinase phosphorylation in vivo. J. Biol. Chem., 1998, 273, 32950-32956.
29. Han, J.; Kim, N.; Joo, H.; Kim, E.; Earm, Y. Atp-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol., 2002, 283, H1545-H1554.
30. Ganz, P. Erectile dysfunction: pathophysiologic mechanisms pointing to underlying cardiovascular disease. Am. J. Cardiol., 2005, 96, 8M-12M.
31. Hodges, L.D.; Kirby, M.; Solanki, J.; O'Donnell, J.; Brody, D.A. The temporal relationship between erectile dysfunction and cardiovascular disease. Int. J. Clin. Prat., 2007, 61, 2019-2025.
32. Srilatha, B.; Adaikan, P.G.; Moore, P.K. Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction- a pilot study. Eur. J. Pharmacol., 2006, 535, 280-282.
33. Srilatha, B.; Adaikan, P.G.; Moore, P.K. Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J. Sex. Med., 2007, 4, 1304-1311.
34. Mirone, V.; Sorrentino, R.; d'Emmanuele di Villa Bianca, R.; Imbimbo, C.; Palmieri, A.; Fusco, F.; Tajana, G.; Cirino, G. A standardized procedure for using human corpus cavernosum strips to evaluate drug activity. J. Pharmacol. Toxicol. Methods, 2000, 44(3), 477-482.
35. Cirino, G.; Sorrentino, R.; di Villa Bianca, R.; Popolo, A.; Calmieri, A.; Imbimbo, C.; Fusco, F.; Longo, N.; Tajana, G.; Ignarro, L.J.; Mirone, V. Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. Proc. Natl. Acad. Sci. USA, 2003, 100(9), 5531-5536.
36. d'Emmanuele di Villa Bianca, R.; Sorrentino, R.; Sorrentino, R.; Imbimbo, C.; Calmieri, A.; Fusco, F.; Maggi, M.; De Palma, R.; Cirino, G.; Mirone, V. Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum. J. Pharmacol. Exp. Ther., 2006, 316(2), 703-708.
37. d'Emmanuele di Villa Bianca, R.; Sorrentino, R.; mafia, P.; Mirone, V.; Imbimbo, C.; Fusco, F.; De Palma, R.; Ignarro, L.J. Cirino Hydrogen sulphide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc. Nat. Acad. Sci. USA., 2009, 106(11), 4513-4518.
38. Carmeliet, P. Angiogenesis in life, disease and medicine. Nature, 2005, 438, 932-936.
39. Carmeliet, P. Angiogenesis in health and disease. Nat. Med., 2003, 9, 653-660.
40. Yang, G.; Wang, R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J., 2006, 20, 553-555.
41. Cai, W.; Wang, M.J.; Moore, P.K.; Jin, T.Y.; Zhu, Y.C. The novel proangiogenic effect of hydrogen sulphide is dependent on Akt phosphorilation. Cardiovasc. Res., 2007, 76, 29-40.
42. Papapetropoulos, A.; pyriochou, A.; Altaany, Z.; Yang, G.; Marazioti, A.; Zhou, Z.; Jeschke, M.G.; Branski, L.K.; Herndon, D.N.; Wang, R.; Szabo, C. Hydrogen sulphide is an endogenous stimulator of angiogenesis. Proc. Natl. Acad. Sci. USA, 2009, 106, 21972-21977.
43. Wang, M.J.; Cai, W.J.; Li, N.; Ding, Y.J.; Chen, Y.; Zhu, Y.C. The hydrogen sulphide donor NaHS promotes angiogenesis in a rat model og hind limb ischemia. Antioxid. Redox Signal., 2010, 12, 1065-1077.
44. Liu, X.; Pan, L.; Zhuo, Y.; Gong, Q.; Rose, P.; Zhu, Y. Hypoxiainducible factor alpha-1 is involved in pro-angiogenic effect of hydrogen sulphide under hypoxic stress. Biol. Pharm. Bull., 2010, 33, 1550-1554.
45. Zhang, Z.; Huang, H.; Liu, P. Hydrogen sulphide contributes to cardioprotection during ischemia-reperfusion injury by opening KATP channels. Can. J. Physiol. Pharmacol., 2007, 85, 1248-1253.
46. Zhong, G. Z.; Li, Y.B.; Liu, X.L.; Guo, L.S.; Chen, M. Hydrogen sulphide opens the KATP channel on rat atrial and ventricular myocytes. Cardiology, 2010, 115, 120-126.
47. Sivarajah, A.; Collino, M.; Yasin, M.; benetti, E.; Gallicchio, M.; Mazzon, E.; Cuzzocrea, S.; Fantozzi, R.; Thiemmernann, C. Antiapoptotic and anti-inflammatory effect of hydrogen sulphide in a rat model of regional myocardial I/R. Shock, 2009, 31, 267-274.
48. Osipov, R.M.; Robich, M.P.; Feng, J.; Liu, Y.; Clements, R.T.; Glazer, H.P.; Sodha, N.R.; Szabo, C.; Bianchi, C.; Sellke, F.W. Effect of hydrogen sulphide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J. Cardiovasc. Pharmacol., 2009, 54, 287-295.
49. Hamacher-Brady, A.; Brady, N.R.; Logue, S.E. Response to myocardial ischemia/reperfusion injury involves BNip 3 and autophagy. Cell Death Differ., 2007, 14, 146-157.
50. Matsui, Y.; Takagi, H.; Qu, X. Distinct roles of autophagy in the heart durino ischemia and reperfusion: role of AMP-activated protein kinase and beclin 1 in mediatine autophagy. Circ. Res., 2007, 100, 914-922.
51. Roberts, M.J.; Young, I.S.; Trouton, T.G.; Trimble, E.R.; Khan, M.M.; Webb, S.W. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet, 1990, 336, 143-145.
52. Kloner, R.A.; Giacomelli, F.; Alker, K.J.; Hale S.L.; Matthews, R.; Bellows, S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation, 1991, 84, 1758-1772.
53. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; mencarelli, A.; Orlandi, S. inihibtion of hydrogen sulphide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology, 2005, 129, 1210-1224.
54. Hu, L.F.; Wong, P.T.; Moore, P.K.; bian, J.S. Hydrogen sulphide attenuates lipopolisaccarides-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J. Neurochem., 2007, 100, 1121-1128.
55. Sodha, N.R.; Clements, R.T.; Feng, J.; Liu, Y.; Bianchi C.; Horvath, E.M.; Szabo, C.; Stahl, G.L.; Sellke, F.W. Hydrogen sulphide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J. Thorac. Cardiovasc. Surg., 2009, 138, 977-980.
56. Lawton, J.S.; Sepic, J.D.; Allen, C.T.; Hsia P.W.; Damiano, R.J. Jr. Myocardial protection with potassium-channel openers is as effective as St. Thomas solution in the rabbit heart. Ann. Thorac. Surg., 1996, 62, 31-39.
57. Sivarajah, A.; McDonald, M.C.; Thiemermann, C. The production of hydrogen sulphide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock, 2006, 26, 154-161.
58. Bian, J.S.; Yong, Q.C.; Pan, T.T.; Feng, Z.N.; Ali, M.Y.; Zhou, S. Role of hydrogen sulphide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. Pharmacol. Exp. Ther., 2006, 316, 670-678.
59. Bliksoen, M.; Kaljusto, M.L.; Vaage, J.; Stenslokken, K.O. Effects of hydrogen sulphide on ischemia-reperfusion injury and ischemic preconditioning in the isolated, perfused rat heart. Eur. J. Cardiothorac. Surg., 2008, 34, 344-349.
60. Elrod, J.W.; Calvert, J.W.; Morrison, J.; Doeller, J.E.; Kraus, D.W.; Tao, L. Hydrogen sulphide attenuates myocardial ischemiareperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. USA, 2007, 104, 15560-15565.
61. Minamishima, S.; Bougaki, M.D.; Sips, P.Y.; De Yu, J.; Minamishima, Y.A.; Elrod, J.W.; Lefer, D.J.; Bloch, K.D.; Ichinose, F. Hydrogen sulphide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation, 2009, 120, 888-896.